RenovoRx Inc (RNXT) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $0.86
• Market Cap: $33.05M
• EPS: $-0.36
• 52-Week High: $1.45
• 52-Week Low: $0.70

Market Sentiment

RenovoRx Inc currently has a Bullish sentiment score of 0.37.

About RenovoRx Inc

RenovoRx, Inc. is a clinical-stage biopharmaceutical company based in Los Altos, California, dedicated to innovating targeted therapies for solid tumors. The company's lead product candidates utilize proprietary delivery systems to maximize the local concentration of therapeutic agents while minimizing systemic exposure, addressing significant unmet needs in oncology. With a robust pipeline and commitment to improving patient outcomes through advanced therapeutic solutions, RenovoRx is positi...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for RenovoRx Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does RNXT pay dividends?

RenovoRx Inc (RNXT) does not currently pay a regular dividend.

What is RNXT's market cap?

RenovoRx Inc (RNXT) has a market capitalization of $33.05M with a current stock price of $0.86.